These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32304146)
1. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections. Speth RC Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146 [No Abstract] [Full Text] [Related]
2. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels. Ferrario CM; Ahmad S; Groban L Nat Rev Cardiol; 2020 Jun; 17(6):378. PubMed ID: 32332868 [No Abstract] [Full Text] [Related]
3. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research. Omar MB Heart Lung; 2020; 49(4):351. PubMed ID: 32327200 [No Abstract] [Full Text] [Related]
4. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2? Patel AB; Verma A Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259 [No Abstract] [Full Text] [Related]
5. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070 [No Abstract] [Full Text] [Related]
6. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week. Brojakowska A; Narula J; Shimony R; Bander J J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? Silhol F; Sarlon G; Deharo JC; Vaïsse B Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915 [No Abstract] [Full Text] [Related]
8. [ACE2 and coronavirus - a question of balance and dynamics?]. Lundström A; Sandén P Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329 [TBL] [Abstract][Full Text] [Related]
9. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19. Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189 [No Abstract] [Full Text] [Related]
10. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus]. Cano F; Gajardo M; Freundlich M Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512 [TBL] [Abstract][Full Text] [Related]
11. COVID-19: The heart of the issue. Woodward B; Kermali M J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802 [No Abstract] [Full Text] [Related]
12. Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2". Weir RAP Circ Res; 2020 Jul; 127(2):e44-e45. PubMed ID: 32614717 [No Abstract] [Full Text] [Related]
13. Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2". Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 Jul; 127(2):e46-e47. PubMed ID: 32614719 [No Abstract] [Full Text] [Related]
14. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565 [TBL] [Abstract][Full Text] [Related]
15. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]. Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743 [No Abstract] [Full Text] [Related]
16. Cardiovascular disease and the impact of COVID-19. Yoganathan A; Sajjad MS; Harky A J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799 [No Abstract] [Full Text] [Related]
17. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure. Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M mBio; 2020 May; 11(3):. PubMed ID: 32444383 [No Abstract] [Full Text] [Related]
18. What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes? John TJ; John K Can J Cardiol; 2020 Jun; 36(6):969.e3. PubMed ID: 32299779 [No Abstract] [Full Text] [Related]
19. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Kansagara D; Mackey K; Vela K Ann Intern Med; 2020 Aug; 173(3):W66. PubMed ID: 32584593 [No Abstract] [Full Text] [Related]
20. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. Diaz JH J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]